Immune Response Induced by Different Manufacturers of Influenza Vaccines.

Trial Profile

Immune Response Induced by Different Manufacturers of Influenza Vaccines.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs GSK 1536489A (Primary) ; Influenza virus vaccine (Primary) ; Influenza virus vaccine (Afluria) (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 29 Apr 2016 Status changed from active, no longer recruiting to completed.
    • 21 Apr 2015 Planned End Date changed from 1 Mar 2015 to 1 Apr 2016 as per ClinicalTrials.gov record.
    • 03 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top